MSL meetings become insights grouped by topic, trial site calls track enrolment and deviations, and possible adverse events and off-label questions are flagged for your safety and compliance teams.
Meetings Acta writes up for pharma & life sciences
CRA: We've enrolled 14 of 20 patients.
Site: One visit was out of window last month.
CRA: Please log the deviation and we'll review on Monday.
Written by Acta
Clinical trial site meeting
What each template writes after a meeting. Example meetings and people.
Pharma
From “MSL meeting with a cardiologist” · sample report
In short
HCP interested in real-world data for older patients; one medical information request.
Possible adverse events are flagged for your safety team to review; they are not confirmed and causality is not assessed.
HCP insights grouped by topic, with open medical questions and requests.
Enrolment, protocol deviations, data queries and site issues, each with an owner.
Possible adverse events flagged for review; not confirmed, causality not assessed.
Turn on the ones you need. Each reads the meeting and writes its report, and skips meetings it isn't meant for.
Insights from a medical science liaison meeting, with requests and safety flags.
Site visit or study call: enrolment, deviations, data queries and site issues.
Preparation for a health-authority meeting: likely questions, positions and evidence gaps.
Rep visit with a healthcare professional: products, objections, samples and safety flags.
More examples in use cases.
Possible adverse events are flagged for your safety team to review. They are not confirmed and causality is not assessed.
Yes. Off-label requests and possible adverse events are flagged for review.
The Regulatory meeting prep template lists likely questions, agreed positions, evidence gaps and owners.
Try Acta for pharma & life sciences.
Free for 15 days. Record your next meeting and get the report.
Start for free